Autocrine human growth hormone promotes tumor angiogenesis in mammary carcinoma

Endocrinology

Volumn 150, Issue 3, 2009, Pages 1341-1352

  Brunet Dunand, Severine E ^a   Vouyovitch, Cecile ^c   Araneda, Silvia ^c   Pandey, Vijay ^a   Vidal, Laurent J P ^a   Print, Cristin ^b   Mertani, Hichem C ^c   Lobie, Peter E ^a,b   Perry, J K ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b UNIVERSITY OF AUCKLAND   (New Zealand)

^c UNIVERSITÉ LYON 1   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; FURIN; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; PROPROTEIN CONVERTASE 1; PROPROTEIN CONVERTASE 2; PROTEIN PROSAAS; UNCLASSIFIED DRUG; CARRIER PROTEIN; HUMAN GROWTH HORMONE; SOMATOTROPIN BINDING PROTEIN; SOMATOTROPIN-BINDING PROTEIN; VASCULOTROPIN A;

ALPHA HELIX; AMINO ACID SEQUENCE; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVE SITE; ENZYME INHIBITION; HYDROPHOBICITY; IN VITRO STUDY; NEUROENDOCRINE SYSTEM; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; VERTEBRATE; XENOPUS; ZEBRA FISH; AUTOCRINE EFFECT; BREAST TUMOR; CANCER INVASION; CARCINOMA; CELL CYCLE; CELL MOTION; CELL PROLIFERATION; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; ENDOTHELIUM CELL; GENE EXPRESSION REGULATION; GENETICS; HUMAN; LYMPHANGIOGENESIS; METABOLISM; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; PHYSIOLOGY; TUMOR CELL CULTURE; VASCULARIZATION;

AUTOCRINE COMMUNICATION; BREAST NEOPLASMS; CARCINOMA; CARRIER PROTEINS; CELL CYCLE; CELL MOVEMENT; CELL PROLIFERATION; ENDOTHELIAL CELLS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMAN GROWTH HORMONE; HUMANS; LYMPHANGIOGENESIS; NEOPLASM INVASIVENESS; NEOVASCULARIZATION, PATHOLOGIC; TUMOR CELLS, CULTURED; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 62749110757     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2008-0608     Document Type: Article

References (84)

1. Huang Z, Bao SD 2004 Roles of main pro- and anti-angiogenic factors in tumor angiogenesis. World J Gastroenterol 10:463-470
2. Banerjee S, Dowsett M, Ashworth A, Martin LA 2007 Mechanisms of disease: angiogenesis and the management of breast cancer. Nat Clin Pract 4:536-550
3. Schneider BP, Miller KD 2005 Angiogenesis of breast cancer. J Clin Oncol 23:1782-1790
4. Adams RH, Alitalo K 2007 Molecular regulation of angiogenesis and lym-phangiogenesis. Nat Rev 8:464-478
5. Hicklin DJ, Ellis LM 2005 Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis. J Clin Oncol 23:1011-1027
6. Ferrara N, Mass RD, Campa C, Kim R 2007 Targeting VEGF-A to treat cancer and age-related macular degeneration. Annu Rev Med 58:491-504
7. Otroek ZK, Makarem JA, Shamseddine AI 2007 Vascular endothelial growth factor family of ligands and receptors: review. Blood Cells Mol Dis 38:258-268
8. Yamazaki Y, Morita T 2006 Molecular and functional diversity of vascular endothelial growth factors. Mol Divers 10:515-527
9. Eppenberger U, Kueng W, Schlaeppi JM,Roesel JL,Benz C, Mueller H, Matter A, Zuber M, Luescher K, Litschgi M, Schmitt M, Foekens JA, Eppenberger-Castori S 1998 Markers of tumor angiogenesis and proteolysis independently define high-and low-risk subsets of node-negative breast cancer patients. J Clin Oncol 16:3129-3136
10. Gasparini G, Toi M, Gion M, Verderio P, Dittadi R, Hanatani M, Matsubara I, Vinante O, Bonoldi E, Boracchi P, Gatti C, Suzuki H, Tominaga T 1997 Prognostic significance of vascular endothelial growth factor protein in node-negative breast carcinoma. J Natl Cancer Inst 89:139-147
11. Linderholm B, Tavelin B, Grankvist K, Henriksson R 1999 Does vascular endothelial growth factor (VEGF) predict local relapse and survival in radiotherapy-treated node-negative breast cancer? Br J Cancer 81:727-732
12. Relf M, LeJeune S, Scott PA, Fox S, Smith K, Leek R, Moghaddam A, White-house R, Bieknell R, Harris AL 1997 Expression of the angiogenic factors vascular endothelial cell growth factor, acidic and basic fibroblast growth factor, tumor growth factor β-1, platelet-derived endothelial cell growth factor, placenta growth factor, and pleiotrophin in human primary breast cancer and its relation to angiogenesis. Cancer Res 57:963-969
13. Toi M, Hoshina S, Takayanagi T, Tominaga T 1994 Association of vascular endothelial growth factor expression with tumor angiogenesis and with early relapse in primary breast cancer. Jpn J Cancer Res 85:1045-1049
14. National Cancer Institute 2008 Bevacizumab. http://www.cancer.gov/ cancertopics/druginfo/fda-bevacizumab. Washington, DC: National Cancer Institute
15. Raccurt M, Lobie PE, Moudilou E, Garcia-Caballero T, Frappart L, Morel G, Mertani HC 2002 High stromal and epithelial human GH gene expression is associated with proliferative disorders of the mammary gland. J Endocrinol 175:307-318
16. Mol JA, Henzen-Logmans SC, Hageman P, Misdorp W, Blankenstein MA, Rijnberk A 1995 Expression of the gene encoding growth hormone in the human mammary gland. J Clin Endocrinol Metab 80:3094-3096
17. Perry JK, Emerald BS, Mertani HC, Lobie PE 2006 The oncogenic potential of growth hormone. Growth Horm IGF Res 16:277-289
18. Zhu T, Starling-Emerald B, Zhang X, Lee KO, Gluckman PD, Mertani HC, Lobie PE 2005 Oncogenic transformation of human mammary epithelial cells by autocrine human growth hormone. Cancer Res 65:317-324
19. Perry JK, Mohankumar KM, Emerald BS, Mertani HC, Lobie PE 2008 The contribution of growth hormone to mammary neoplasia. J Mammary Gland Biol Neoplasia 13:131-145
20. Waters MJ, Conway-Campbell BL 2004 The oncogenic potential of autocrine human growth hormone in breast cancer. Proc Natl Acad Sci USA 101:14992-14993
21. Mukhina S, Mertani HC, Guo K, Lee KO, Gluckman PD, Lobie PE 2004 Phenotypic conversion of human mammary carcinoma cells by autocrine human growth hormone. Proc Natl Acad Sci USA 101:15166-15171
22. Corbacho AM, Martinez De La Escalera G, Clapp C 2002 Roles of prolactin and related members of the prolactin/growth hormone/placental lactogen family in angiogenesis. J Endocrinol 173:219-238
23. Hongo M, Ryoke T, Schoenfeld J, Hunter J, Dalton N, Clark R, LoweD, Chien K, Ross Jr J 2000 Effects of growth hormone on cardiac dysfunction and gene expression in genetic murine dilated cardiomyopathy. Basic Res Cardiol 95:431-441
24. Cittadini A, Isgaard J, Monti MG, Casaburi C, Di Gianni A, Serpico R, Iaccarino G, Sacca L 2003 Growth hormone prolongs survival in experimental postinfarction heart failure. J Am Coll Cardiol 41:2154-2163
25. Colao A, Di Somma C, Savanelli MC, De Leo M, Lombardi G 2006 Beginning to end: cardiovascular implications of growth hormone (GH) deficiency and GH therapy. Growth Horm IGF Res 16(Suppl A):S41-S48
26. Thum T, Bauersachs J 2006 Growth hormone regulates vascular function:what we know from bench and bedside. Growth Horm IGF Res 62:29-32
27. Oomen PH, Beentjes JA, Bosma E, Smit AJ, Reitsma WD, Dullaart RP 2002 Reduced capillary permeability and capillary density in the skin of GH-defi-cient adults: improvement after 12 months GH replacement. Clin Endocrinol (Oxf) 56:519-524
28. Kusano K, Tsutsumi Y, Dean J, Gavin M, Ma H, Silver M, Thome T, Zhu Y, Losordo DW, Aikawa R 2007 Long-term stable expression of human growth hormone by rAAV promotes myocardial protection post-myocardial infarction. J Mol Cell Cardiol 42:390-399
29. Frerich B, Kurtz-Hoffmann J, Lindemann N 2005 Influence of growth hormone on maintenance of capillary-like structures in an in vitro model of stromal vascular tissue: results from morphometric analysis. Artif Organs 29:338-341
30. Rong SL, Lu YX, Liao YH, Wang XL, Wang YJ, Chang C, Wang YQ, Liu QY, Gao YZ, Mi SH 200S Effects of transplanted myoblasts transfected with human growth hormone gene on improvement of ventricular function of rats. Chin Med J (Engl) 121:347-354
31. Smith LE, Kopchick JJ, Chen W, Knapp J, Kinose F, Daley D, Foley E, Smith RG, Schaeffer JM 1997 Essential role of growth hormone in ischemia-induced retinal neovascularization. Science 276:1706-1709
32. Struman I, Bentzien F, Lee H, Mainfroid V, D'Angelo G, GoffinV, Weiner RI, Martial JA 1999 Opposing actions of intact and N-terminal fragments of the human prolactin/growth hormone family members on angiogenesis: an efficient mechanism for the regulation of angiogenesis. Proc Natl Acad Sci USA 96:1246-1251
33. Gould J, Aramburo C, Capdevielle M, Scanes CG 1995 Angiogenic activity of anterior pituitary tissue and growth hormone on the chick embryo chorioallantoic membrane: a novel action of GH. Life Sci 56:587-594
34. Rymaszewski Z, Cohen RM, Chomczynski P 1991 Human growth hormone stimulates proliferation of human retinal microvascular endothelial cells in vitro. Proc Natl Acad Sci USA 88:617-621
35. Mertani HC, Garcia-Caballero T, Lambert A, Gerard F, Palayer C, Boutin JM, Vonderhaar BK, Waters MJ, Lobie PE, Morel G 1998 Cellular expression of growth hormone and prolactin receptors in human breast disorders, Int J Cancer 79:202-211
36. Lincoln DT, Singal PK, Al-Banaw A 2007 Growth hormone in vascular pathology: neovascularization and expression of receptors is associated with cellular proliferation. Anticancer Res 27:4201-4218
37. Temmim L,Kolle S, Baker H, Sinowatz F 2000 Expression of growth hormone receptor in human liposarcomas and lipomas. Oncol Rep 7:757-760
38. Lobie PE, Breipohl W, Aragon JG, Waters MJ 1990 Cellular localization of the growth hormone receptor/binding protein in the male and female reproductive systems. Endocrinology 126:2214-2221
39. Mertani HC, Zhu T, Goh EL, Lee KO, Morel G, Lobie PE 2001 Autocrine human growth hormone (hGH) regulation of human mammary carcinoma cell gene expression. Identification of CHOP as a mediator of hGH-stimulated human mammary carcinoma cell survival. J Biol Chem 276:21464-21475
40. Barnard R, Bundesen PG, Rylatt DB, Waters MJ 1985 Evidence from the use of monoclonal antibody probes for structural heterogeneity of the growth hormone receptor. Biochem J 231:459-468
41. Kaulsay KK, Zhu T, Bennett W, Lee KO, Lobie PE 2001 The effects of autocrine human growth hormone (hGH) on human mammary carcinoma cell behavior are mediated via the hGH receptor. Endocrinology 142:767-777
42. Araneda S, Pelloux S, Radicella JP, Angulo J, Kitahama K, Gysling K, Forray MI 2005 8-Oxoguanine DNA glycosylase, but not Kinl7 protein, is translo cated and differentially regulated by estrogens in rat brain cells. Neuroscience 136:135-146
43. Kaulsay KK, Mertani HC, Tornell J, Morel G, Lee KO, Lobie PE 1999 Autocrine stimulation of human mammary carcinoma cell proliferation by human growth hormone. Exp Cell Res 250:35-50
44. Pandey V, Perry JK, Mohankumar KM, Kong XJ, Liu SM, Wu ZS, Mitchell MD, Zhu T, Lobie PE 2008 Autocrine human growth hormone stimulates oncogenicity of endometrial carcinoma cells. Endocrinology 149:3909-3919
45. Ades EW, Candal FJ, Swerlick RA, George VG, Summers S, Bosse DC, Lawley TJ 1992 HMEC-1: establishment of an immortalized human microvascular endothelial cell line. J Investigative Dermatol 99:683-690
46. Bouis D, Hospers GA, Meijer C, Molema G, Mulder NH 2001 Endothelium in vitro: a review of human vascular endothelial cell lines for blood vessel-related research. Angiogenesis 4:91-102
47. Lamalice L, Le Boeuf F, Huot J 2007 Endothelial cell migration during angiogenesis. Circ Res 100:782-794
48. Auerbach R, Lewis R, Shinners B, Kubai L, Akhtar N 2003 Angiogenesis assays: a critical overview. Clin Chem 49:32-40
49. Kopchick JJ, Parkinson C, Stevens EC, Trainer PJ 2002 Growth hormone receptor antagonists: discovery, development, and use in patients with acromegaly. Endocr Rev 23:623-646
50. van der Lely AJ, Kopchick JJ 2006 Growth hormone receptor antagonists. Neuroendocrinology 83:264-268
51. Kahn HJ, Marks A 2002 A new monoclonal antibody, D2-40, for detection of lymphatic invasion in primary tumors. Lab Invest 82:1255-1257
52. Fox SB, Generali DG, Harris AL 2007 Breast tumour angiogenesis. Breast Cancer Res 9:216
53. Shibuya M 2006 Differential roles of vascular endothelial growth factor receptor-1 and receptor-2 in angiogenesis. J Biochem Mol Biol 39:469-478
54. Ikeo S, Yamauchi K, Shigematsu S, Nakajima K, Aizawa T, Hashizume K 2001 Differential effects of growth hormone and insulin-like growth factor I on human endothelial cell migration. Am J Physiol Cell Physiol 280:0255-C1261
55. Xu XQ, Emerald BS, Goh EL, Kannan N, Miller LD, Gluckman PD, Liu ET, Lobie PE 2005 Gene expression profiling to identify oncogenic determinants of autocrine human growth hormone in human mammary carcinoma. J Biol Chem 280:23987-24003
56. Liu N, Mertani HC, Norstedt G, Tornell J, Lobie PE 1997 Mode of the autocrine/paracrine mechanism of growth hormone action. Exp Cell Res 237:196-206
57. Wajnrajch MP 2005 Physiological and pathological growth hormone secretion. J Pediatr Endocrinol Metab 18:325-338
58. Davey HW, Wilkins RJ, Waxman DJ 1999 STAT5 signaling in sexually dimorphic gene expression and growth patterns. Am J Hum Genet 65:959-965
59. ZhuZ, Mukmna S, Zhu T,Mertani HC, Lee KO, Lobie PE 2005 p44/42MAP kinase-dependent regulation of catalase by autocrine human growth hormone protects human mammary carcinoma cells from oxidative stress-induced apoptosis. Oncogene 24:3774-3785
60. York RD, Yao H, Dillon T, Ellig CL, Eckert SP, McCleskey EW, Stork PJ 1998 Rap 1 mediates sustained MAP kinase activation induced by nerve growth factor. Nature 392:622-626
61. Zhu T, Ling L, Lobie PE 2002 Identification of a J Aid-independent path way regulating growth hormone (GH)-stimulated p44/42 mitogen-activated protein kinase activity. GH activation of Ral and phospholipase D is Src-depen-dent. J Biol Chem 277:45592-45603
62. Rodrigues S, Van Aken E, Van Bocxlaer S, Attoub S, Nguyen QD, Bruyneel E, Westley BR, May FE, Thim L, Mareel M, Gespach C, Em ami S 2003 Trefoil peptides as proangiogenic factors in vivo and in vitro: implication of cyclooxygenase-2 and EGF receptor signaling. FASEB J 17:7-16
63. Thum T, Hoeber S, Froese S, Klink I, Stichtenoth DO, Galuppo P, Jakob M, Tsikas D, Anker SD, Poole-Wilson PA, Borlak J, Ertl G, Bauersachs J 2007 Age-dependent impairment of endothelial progenitor cells is corrected by growth-hormone-mediated increase of insulin-like growth-factor-1. Circ Res 100:434-443
64. Gennigens C, Menetrier-Caux C, Droz JP 2006 Insulin-like growth factor (IGF) family and prostate cancer. Crit Rev Oncol Hematol 58:124-145
65. Conti E, Carrozza C, Capoluongo E, Volpe M, Crea F, Zuppi C, Andreotti F 2004 Insulin-like growth factor-1 as a vascular protective factor. Circulation 110:2260-2265
66. Wickman A, Jonsdottir IH, Bergstrom G, Hedin L 2002 GH and IGF-I regulate the expression of endothelial nitric oxide synthase (eNOS) in cardiovascular tissues of hypophysectomized female rats. Eur J Endocrinol 147:523-533
67. Thum T, Tsikas D, Frolich JC, Borlak J 2003 Growth hormone induces eNOS expression and nitric oxide release in a cultured human endothelial cell line. FEBS Lett 555:567-571
68. Li G, Del Rincon JP, Jahn LA, Wu Y, Gaylinn B, Thorner MO, Liu Z 2008 Growth hormone exerts acute vascular effects independent of systemic or muscle insulin-like growth factor I. J Clin Endocrinol Metab 93:1379-1385
69. Fukumura D, Kashiwagi S, Jain RK 2006 The role of nitric oxide in tumour progression. Nat Rev Cancer 6:521-534
70. Devin JK, Vaughan DE, Blevins Jr LS, Chen Q, Covington J, Verity DK, Young PP 2007 Low-dose growth hormone administration mobilizes endothelial progenitor cells in healthy adults. Growth Horm IGF Res 18:253-263
71. Ball SG, Shuttlewoith CA, Kielty CM 2007 Mesenchymal stem cells and neovascularization: role of platelet-derived growth factor receptors. J Cell Mol Med 11:1012-1030
72. Siejka A, Lawnicka H, Komorowski J, Schally AV, Stepien T, Krupinski R, Stepien H 2003 GH-RH antagonist (MZ-4-71) inhibits VEGF secretion and proliferation of murine endothelial cells. Life Sci 72:2473-2479
73. Kanashiro CA, Schally AV, Zarandi M, Hammann BD, Varga JL 2007 Alterations of EGFR/HER, angiogenesis and apoptosis pathways after therapy with antagonists of growth hormone releasing hormone and bombesin in non-small cell lung cancer, lnt J Oncol 30:1019-1028
74. Schally AV, Varga JL, Engel JB 2008 Antagonists of growth-hormone-releasing hormone: an emerging new therapy for cancer. Nat Clin Pract Endocrinol Metab 4:33-43
75. Szepeshazi K, Schally AV, Armatis P, Groot K, Hebert F, Feil A, Varga JL, Halmos G 2001 Antagonists of GHRH decrease production of GH and IGF-I in MXT mouse mammary cancers and inhibit tumor growth. Endocrinology 142:4371-4378
76. Goldhar AS, Vonderhaar BK, Trott JF, Hovey RC 2005 Prolactin-induced expression of vascular endothelial growth factor via Egr-1. Mol Cell Endocrinol 232:9-19
77. Kelly PA, Ali S, Rozakis M, Goujon L, Nagano M, Pellegrini I, Gould D, Djiane J,Edery M, Finidori J, Postel-Vinay MC 1993 The growth hormone/prolactin receptor family. Recent Prog Horm Res 48:123-164
78. Cao Y,Zhong W 2007 Tumor-derived lymphangiogenic factors and lymphatic metastasis. Biomed Pharmacother 61:534-539
79. Zwaans BM, Bielenberg DR 2007 Potential therapeutic strategies for lymphatic metastasis, Microvasc Res 74:145-158
80. Bjorndahl MA, Cao R, Burton JB, Brakenhielm E, Religa P, Gaiter D, Wu L, Cao Y 2005 Vascular endothelial growth factor-a promotes peritumoral lymphangiogenesis and lymphatic metastasis. Cancer Res 65:9261-9268
81. Hirakawa S, Kodama S, Kunstfeld R, Kajiya K, Brown LF, Detmar M 2005 VEGF-A induces tumor and sentinel lymph node lymphangiogenesis and promotes lymphatic metastasis. J Exp Med 201:1089-1099
82. Nagy JA, Vasile E, Feng D, Sundberg C, Brown LF, Detmar MJ, Lawitts JA, Benjamin L, Tan X, Manseau EJ, Dvorak AM, Dvorak HF 2002 Vascular permeability factor/vascular endothelial growth factor induces lymphangiogenesis as well as angiogenesis. J Exp Med 196:1497-1506
83. Banziger-Tobler NE, Halin C, Kajiya K, Detmar M 2008 Growth hormone promotes lymphangiogenesis. Am J Pathol 173:586-597
84. Ferrara N, Kerbel RS 2005 Angiogenesis as a therapeutic target. Nature 438:967-974